earnings
confidence high
sentiment positive
materiality 0.65
Champions Oncology Q1 revenue up 8.8% to $15.2M; adjusted EBITDA $671K vs $59K
CHAMPIONS ONCOLOGY, INC.
- Revenue $15.2M, +8.8% YoY; oncology services margin improved to 51% from 43%.
- Adjusted EBITDA $671K vs $59K; net loss narrowed to $426K from $466K.
- Sales & marketing expense up 66.6% to $3.1M on commercial expansion.
- Cash $4.4M, no debt; net cash used in ops ~$492K.
- R&D up 12.6% to $2.3M, driven by Corellia share-based compensation.